Fulgent Genetics
FLGT
275 hedge funds and large institutions have $759M invested in Fulgent Genetics in 2022 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 107 increasing their positions, 68 reducing their positions, and 59 closing their positions.
57% more repeat investments, than reductions
Existing positions increased: 107 | Existing positions reduced: 68
2.25% more ownership
Funds ownership: 37.69% → 39.94% (+2.2%)
7% more call options, than puts
Call options by funds: $48.1M | Put options by funds: $44.8M
8% less funds holding
Funds holding: 298 → 275 (-23)
33% less capital invested
Capital invested by funds: $1.13B → $759M (-$371M)
36% less first-time investments, than exits
New positions opened: 38 | Existing positions closed: 59
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$18.3M |
| 2 |
PWAM
Park West Asset Management
San Francisco,
California
|
+$16.5M |
| 3 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$10.2M |
| 4 |
Renaissance Technologies
New York
|
+$6.36M |
| 5 |
Goldman Sachs
New York
|
+$5.51M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$11M |
| 2 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$9.48M |
| 3 |
BlackRock
New York
|
-$8.35M |
| 4 |
JAM
Jupiter Asset Management
London,
United Kingdom
|
-$4.34M |
| 5 |
BAMF
BI Asset Management Fondsmaeglerselskab
Kobenhavn,
Denmark
|
-$4.03M |
FLGT Hedge Fund Activity: Q1 2022 in Review
275 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Fulgent Genetics (FLGT) for Q1 2022, worth a combined $759M — down 33% from $1.13B a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of FLGT and 38 opened new positions — a net loss of 21 holders — while 68 trimmed existing stakes and 107 added.
The largest buyer was Millennium Management, adding an estimated $18.3M. The largest seller was Citadel Advisors, cutting an estimated $11M.
- 275 institutional investors held Fulgent Genetics (FLGT) as of Q1 2022, down from 298 in Q4 2021.
- Funds reported $759M of Fulgent Genetics stock for Q1 2022, down 33% quarter-over-quarter.
- 38 funds opened new Fulgent Genetics positions in Q1 2022 and 59 closed out, a net change of -21 holders.
- The largest Fulgent Genetics buyer in Q1 2022 was Millennium Management, an estimated $18.3M added.
- The largest Fulgent Genetics seller in Q1 2022 was Citadel Advisors, an estimated $11M sold.
Based on aggregated 13F filings for Q1 2022.